Literature DB >> 12187109

Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine.

Ayumi Shimizu-Tokiwa1, Mami Kobata, Hiroaki Io, Noriyoshi Kobayashi, Ichiyu Shou, Kazuhiko Funabiki, Mitsumine Fukui, Satoshi Horikoshi, Isao Shirato, Kensuke Saito, Yasuhiko Tomino.   

Abstract

We determined the relationship between the levels of serum cystatin C or creatinine (s-Cr) and the grade of creatinine clearance (CCr) in patients with various glomerular diseases. Serum samples from 96 patients with glomerular diseases were obtained from our hospital. The levels of serum cystatin C were measured using the Dade Behring Cystatin C assay with the automated Dade Behring Nephelometer II (BNII). CCr levels were classified into six groups according to the Guidelines of the Japanese Society of Nephrology as follows: grade 1 (normal renal function); grade 2 (slight decrease of renal function); grade 3 (moderate decrease of renal function); grade 4 (severe decrease of renal function); grade 5 (renal failure), and grade 6 (uremia). The mean levels of serum cystatin C in grade 3 patients were significantly higher than those in grade 1. The mean levels of serum cystatin C in grades 4, 5 and 6 patients were also significantly higher than those in grade 1. However, the mean levels of serum Cr in grade 3 patients were not significantly higher than those in grade 1. The levels of s-Cr in grades 4, 5 or 6 patients were significantly higher than those in grade 1. In this study, an increase of serum cystatin C levels occurred earlier than that of s-Cr in various glomerular diseases. It appears that the levels of serum cystatin C may provide early prognostic marker of patients with various glomerular diseases rather than the levels of s-Cr. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12187109     DOI: 10.1159/000064453

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

Review 1.  Commentary: clinical diagnostic use of cystatin C.

Authors:  Davis Massey
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  From Analysis of Ischemic Mouse Brain Proteome to Identification of Human Serum Clusterin as a Potential Biomarker for Severity of Acute Ischemic Stroke.

Authors:  Hailong Song; Hui Zhou; Zhe Qu; Jie Hou; Weilong Chen; Weiwu Cai; Qiong Cheng; Dennis Y Chuang; Shanyan Chen; Shuwei Li; Jilong Li; Jianlin Cheng; C Michael Greenlief; Yuan Lu; Agnes Simonyi; Grace Y Sun; Chenghan Wu; Jiankun Cui; Zezong Gu
Journal:  Transl Stroke Res       Date:  2018-11-21       Impact factor: 6.829

3.  Assessment of serum cystatin C in children with congenital solitary kidney.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Iwona Jadeszko; Tadeusz Porowski; Anna Biernacka; Alicja Niewiarowska; Agata Korzeniecka-Kozerska
Journal:  Pediatr Nephrol       Date:  2006-03-30       Impact factor: 3.714

4.  Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy.

Authors:  Ayumi Shimizu; Satoshi Horikoshi; Hisaki Rinnno; Mami Kobata; Kensuke Saito; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

5.  Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients.

Authors:  Eun Hee Kim; Ji Hee Yu; Sang Ah Lee; Eui Young Kim; Won Gu Kim; Seung Hun Lee; Eun Hee Cho; Eun Hee Koh; Woo Je Lee; Min-Seon Kim; Joong-Yeol Park; Ki-Up Lee
Journal:  Korean Diabetes J       Date:  2010-04-30

6.  Response: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100).

Authors:  Eun Hee Kim; Ki-Up Lee
Journal:  Korean Diabetes J       Date:  2010-06-30

7.  Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy.

Authors:  Wouter J Kikkert; Bimmer E Claessen; Gregg W Stone; Roxana Mehran; Bernhard Witzenbichler; Bruce R Brodie; Jochen Wöhrle; Adam Witkowski; Giulio Guagliumi; Krzysztof Zmudka; José P S Henriques; Jan G P Tijssen; Elias A Sanidas; Vasiliki Chantziara; Ke Xu; George D Dangas
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

8.  Severity of acute kidney injury and two-year outcomes in critically ill patients.

Authors:  Lior Fuchs; Joon Lee; Victor Novack; Yael Baumfeld; Daniel Scott; Leo Celi; Tal Mandelbaum; Michael Howell; Daniel Talmor
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

9.  Beta-trace protein, a new marker of GFR, may predict the early prognostic stages of patients with type 2 diabetic nephropathy.

Authors:  Mami Kobata; Ayumi Shimizu; Hisaki Rinno; Chieko Hamada; Kunimi Maeda; Mitsumine Fukui; Kensuke Saito; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

10.  Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients.

Authors:  Tsutomu Nakamura; Takeshi Ioroi; Toshiyuki Sakaeda; Masanori Horinouchi; Nobuhide Hayashi; Kensuke Saito; Mitsuro Kosaka; Noboru Okamura; Keiichi Kadoyama; Shunichi Kumagai; Katsuhiko Okumura
Journal:  Int J Med Sci       Date:  2006-05-17       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.